[Skip to content] [CSUSM Home] [CSUSM Search] [Help for this Site]
Page Last Revised on 03/02/2008

 


 

Bianca R. Mothé                 

 

Associate Professor of Biological Sciences, Ph.D. Molecular and Cellular Pathology 2002: University of Wisconsin-Madison. Dr. Mothé started her appointment at CSUSM in Fall 2003. Dr. Mothé conducted her postdoctoral work at Epimmune, Inc in San Diego, CA. Her areas of specialization are immunology and virology, with research interests in designing novel vaccines for rapidly mutating viruses, including HIV and SIV.

Research Students (dates research conducted in lab)
Barbara Stewart (Masters student, 2004-2005) currently in Ph.D. program in Biodefense at SUNY-Albany
Scott Worsley (Masters student, 2004-present)
Javier Fernandez (Masters student, 2005- present)
Stephanie Stogiera (Undergraduate student, 2003-2005) currently in Ph.D. program at the University of Michigan
Melissa Thompson (Undergraduate student, 2003-2005) currently in Physician’s Assistant program in Pennsylvania
Alena Christina Ramirez (Undergraduate student, 2004-present)
Claudia Pawlowski (Undergraduate student, 2004-present)
Cynthia Basa-Morales (Undergraduate student, 2004-present)
 

PUBLICATIONS

Geisbert, T.W., Jones, S., Fritz, E.A., Shurtleff, A.C., Geisbert, J.B., Liebscher, R., Grolla, A., Stroher, U., Fernando, L., Daddario, K.M., Guttieri, M.C., Mothe, B.R., Larsen, T., Hensley, L.E., Jahrling, P.B., Feldmann, H. Development of a new vaccine for the prevention of Lassa fever. PLoS Med. 2005 Jun;2(6):e183. Epub 2005 Jun 28.

Bui, H.H., Sidney, J., Peters, B., Sathiamurthy, M., Sinichi, A., Purton, K.A., Mothe, B.R., Chisari, F.V., Watkins, D.I., Sette, A. Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications. Immunogenetics. 2005 Jun;57(5):304-14. Epub 2005 May 3.

Altfeld, M., Allen, T.M., Kalife, E., Frahm, N., Addo, M.M., Mothe, B.R., Rathod, A., Reyor, L., Harlow, J., Yu, X., Perkins, B., Sidney, J., Alter, G., Lichterfeld, M., Sette, A., Rosenberg, E.S., Goulder, P.J.R., Brander, C., Walker, B.D. The majority of currently circulating HIV-1 clade B viruses fail to prime CTL responses against an otherwise immunodominant HLA-A2-restricted epitope. Journal of Virology. 2005 Apr;79(8):5000-5.

Tangri, S., Mothé, B.R., Eisenbraun, J., Sidney, J., Southwood, S., Briggs, K., Zinckgraf, J., Bilsel, P., Newman, M., Chesnut, R., LiCalsi, C., Sette, A. Rationally Engineered Therapeutic Proteins with Reduce Immunogenicity. Journal of Immunology. 2005 Mar 15;174(6):3187-96.

Sette, A, Sidney, J., Bui, H.-H., del Guercio, M.-F., Alexander, J., Loffredo, J., Watkins, D.I., and Mothé, B.R. Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity. Immunogenetics. 2005 Apr;57(1-2):53-68. Epub 2005 Mar 4.

Loffredo, J.T., Sidney, J., Wojewoda, C., Dodds, E., Napoé, G., Mothé, B.R., O’Connor, D.H., Wilson, N.A., Watkins, D.I., Sette, A., Seventeen New Simian Immunodeficiency Virus-Derived Cytotoxic T-Lymphocyte Epitopes Identified by Refinement of the Peptide-Binding Motif of the High Frequency Molecule, Mamu-A*02. Journal of Immunology. 2004 Oct 15;173(8):5064-76.

Allen, T.M., Altfeld, M., Yu, H.G., O’Sullivan, K.M., Lichterfeld, M., Lee, P., Le Gall, S., Mothé, B.R., Cohen, D.E., Freedberg, K.A., Sette, A., Rosenberg, E.S., Goulder, P.J.R., Brander, C., Walker, B.D. Selection. Transmission and Reversion of an Antigen Processing CTL Escape Mutation in HIV-1. Journal of Virology. 2004 Jul;78(13):7069-78.

Friedrich, T.C., Dodds, E.J., Yant, L., Rudersdorf, R., Cullen, C., Evans, D.T., Desrosiers, R.C., Mothé, B.R., Sidney, J., Sette, A., Kunstman, K., Wolinsky, S., Piatak, M., Lifson, J., McDermott, A., Wilson, N., O’Connor, D.H., Watkins, D.I. Reversion of transmitted cytotoxic T-lymphocyte (CTL) escape variant immunodeficiency viruses in vivo. Nat Med. 2004 Mar;10(3):275-81. Epub 2004 Feb 15.

O’Connor, D.H.*, Mothé, B.R.*, Weinfurter, J.*, Fuenger, S., Rehrauer, W., Jing, P., Rudersdorf, R.A., Liebl, M.E., Krebs, K., Vasquez, J., Dodds, E., Loffredo, J., McDermott, A.B., Allen, T.M., Wang, C., Doxiadis, G.G.M., Montefiori, D.C., Burton, D.R., Allison, D.B., Wolinsky, S.M., Bontrop, R.E., Picker, L.J, Watkins, D.I.. MHC Class I Alleles Associated With Slow SIV Disease Progression Restrict Dominant Acute Phase Cytotoxic T Lymphocyte Responses. Journal of Virology, 2003 77:9029-40.
*These authors contributed equally


Mothé, B.R., Weinfurter, J., Wang, C., Rehrauer, W., Wilson, N., Allen, T.M., Allison, D.B., Watkins, D.I. Expression of the MHC class I molecule Mamu-A*01 is Associated with Control of SIVmac239 Replication. Journal of Virology. 2003 Feb.; 77(4):2736-40

Allen, T.M., Jing, P., Calore, B., Horton, H., O’Connor, D.H., Hanke, T., Piekarczyk, M., Ruddersdorf, R., Mothé, B.R., Emerson, C., Wilson, N., Lifson, J.D., Belyakov, I.M., Berzofsky, J.A., Wang, C., Allison, D.B., Montefiori, D.C., Desrosiers, R.C.,Wolinsky, S., Kunstman, K.J., Altman, J.D., Sette, A., McMichael, A.J., Watkins, D.I. Effects of CTL Directed Against a Single SIV Gag CTL Epitope on the Course of SIVmac239 Infection. Journal of Virology. 2002 Oct.; 76(20):10507-11

Mothé, B.R., Sidney, J., Dzuris, J.L., Liebl, M.E., Fuenger, S., Watkins, D.I., and Sette, A. Characterization of the peptide binding specificity of Mamu-B*17 and identification of Mamu-B*17-restricted epitopes derived from SIV proteins. Journal of Immunology. 2002. 169(1):210-219.

O'Connor, D.H., Allen, T.M., Vogel, T.U., Jing, P., DeSouza, I.P., Dodds, E., Dunphy, E.J., Melsaether, C., Mothé, B., Yamamoto, H., Horton, H., Wilson N, Hughes, A.L., Watkins, D.I. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection. Nat Med. 2002. May;8(5):493-9.

Mothé, B.R.*, Horton, H.*, Carter, D.K., Allen, T.M., Liebl, M.E., Skinner, P., Vogel, T.U., Fuenger, S., Vielhuber, K., Rehrauer, W., Wilson, N., Franchini, G., Altman, J.D., Haase, A., Picker, L.J., Allison, D.B., Watkins, D.I. Dominance of CD8 Responses Specific For Epitopes Bound by a Single MHC Class I Molecule During the Acute Phase of Viral Infection. Journal of Virology, 2002 Jan.; 76 (2): 875-884.
*These authors contributed equally

Allen, T.M., Mortara, L., Mothé, B.R., Liebl, M., Jing, P., Calore, B., Piekarczyk, M., Ruddersdorf, R., O’Connor, D.H., Fuller, D., Wang, X., Altman, J.D., Sette, A., Desrosiers, R., Sutter, G., Watkins, D.I. A DNA/MVA Vaccine Expressing Tat is Unable to Control Virus Replication in SIVmac239 Challenged Rhesus Macaques. Journal of Virology, 2002 April.; 76 (8): 4108-12.

Allen, T.M.*, Mothé, B.R.*, Sydney, J., Jing, P., Dzuris, J.L., Liebl, M.E., Vogel, T.U., O’Connor, D.H., Wang, X., Wussow, M.C., Thomson, J.A., Altman, J.D., Watkins, D.I., Sette, A. CD8+ Lymphocytes From SIV-Infected Rhesus Macaques Recognize 27 Different Peptides Bound by the MHC Class I Molecule Mamu- A*01: Implications for Vaccine Design and Testing. Journal of Virology, 2001 Jan.; 75 (2): 738- 749.
*These authors contributed equally

Sidney, J., Dzuris, J., Newman, M., Johnson, R.P., Amitindir, K., Appela, E., Mothé, B.R., Watkins, D.I., Sette, A. Definition of the Mamu-A*01 peptide binding specificity: application to the identification of wild type and optimized ligands from SIV regulatory proteins. Journal of Immunology, 2000 Dec 1; 165(11):6387-99.

Allen, T.M., O'Connor, D.H., Jing, P., Dzuris, J.L., Mothé, B.R., Vogel, T.U., Dunphy, E., Liebl, M.E., Emerson, C., Wilson, C., Kunstman, K.J., Wang, X., Allison, D.B., Hughes, A.L., Desrosiers, R.C., Altman, J.D., Wolinsky, S.M., Sette, A, Watkins, D.I. Tat- Specific Cytotoxic T Lymphocytes Select for SIV Escape Variants During Resolution of Primary Viraemia. Nature, 2000 Sep 21; 407(6802):386-90.

Allen, T.M., Vogel, T.U., Fuller, D.H., Mothé, B.R., Steffen, S., Boyson, J.E., Shipley, T., Fuller, J., Hanke, T., Sette, A., Altman, J.D., Moss, B., McMichael, A.J., Watkins, D.I. Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA Prime/Modified vaccinia virus ankara boost regimen. Journal of Immunology, 2000 May 1;164(9):4968-78

 

 

 

Click Here To Go To Faculty Member's Home Page